Fetal echocardiography at 11–13 weeks by transabdominal high‐frequency ultrasound

To assess the accuracy of fetal echocardiography at 11–13 weeks performed by well‐trained obstetricians using a high‐frequency linear ultrasound transducer.

[1]  B. Thilaganathan,et al.  Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies , 2004, Heart.

[2]  M. Bellotti,et al.  Fetal echocardiography at the time of the nuchal translucency scan , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  A. Cook,et al.  Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. , 1994, Journal of the American College of Cardiology.

[4]  E. Tegnander,et al.  Prenatal detection of heart defects in a non‐selected population of 30 149 fetuses—detection rates and outcome , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[5]  L. Allan,et al.  Echocardiographic detection of congenital heart disease in the fetus: present and future. , 1995, British heart journal.

[6]  A. Fanaroff.  Prenatal detection of heart defects in a non-selected population of 30 149 fetuses–detection rates and outcome , 2008 .

[7]  G. D'ottavio,et al.  Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of operator experience , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  K. Nicolaides,et al.  Fetal cardiac abnormalities identified prior to 14 weeks' gestation , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  J. Simpson,et al.  An echocardiographic study of diagnostic accuracy, prediction of surgical approach, and outcome for fetuses diagnosed with discordant ventriculo-arterial connections , 2007, Cardiology in the Young.

[10]  K. Nicolaides,et al.  Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6‐week scan , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[11]  K. Nicolaides,et al.  Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[12]  K. Nicolaides,et al.  Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study , 1999, BMJ.

[13]  A. Ebrashy,et al.  13–14‐week fetal anatomy scan: a 5‐year prospective study , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  I. Staboulidou,et al.  Two‐stage first‐trimester screening for trisomy 21 by ultrasound assessment and biochemical testing , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[15]  J. Ioannidis,et al.  Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. , 2003, American journal of obstetrics and gynecology.

[16]  L. Allan,et al.  Screening for congenital heart disease prenatally. Results of a 2½‐year study in the South East Thames Region , 1992, British journal of obstetrics and gynaecology.

[17]  R. Bain,et al.  A randomized trial of prenatal ultrasonographic screening: impact on maternal management and outcome. RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) Study Group. , 1993, American journal of obstetrics and gynecology.